thromboxanes has been researched along with Hemorrhage in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bugert, P; Schedel, A; Weiskirchen, R; Yagmur, E | 1 |
| Becker, RC; Conley, PB; French, PA; Gachet, C; Goodman, SG; Kuliopulos, A; Moliterno, DJ; Roe, MT; Smyth, SS; Steinhubl, SR; Weitz, JI; Woulfe, DS | 1 |
| D'Angelo, A; Galli, G; Mannucci, PM; Pareti, FI; Sautebin, L; Smith, JB | 1 |
| Born, GV; Shafi, S; Thorngren, M | 1 |
| Bunting, S; Moncada, S; Vane, JR | 1 |
| Schafer, AI | 1 |
| Moncada, S | 1 |
| de Lima, WT; Jancar, S; Sirois, P | 1 |
| Lecompte, T; Samama, M | 1 |
3 review(s) available for thromboxanes and Hemorrhage
| Article | Year |
|---|---|
G-protein-coupled receptors as signaling targets for antiplatelet therapy.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Drug Design; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptor, PAR-1; Receptors, G-Protein-Coupled; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Receptors, Thrombin; Receptors, Thromboxane; Signal Transduction; Thrombin; Thromboxanes | 2009 |
The prostacyclin--thromboxane A2 balance: pathophysiological and therapeutic implications.
Topics: Animals; Cytochrome P-450 Enzyme System; Diet; Epoprostenol; Hemorrhage; Humans; Intramolecular Oxidoreductases; Platelet Aggregation; Prostaglandin Endoperoxides; Thrombosis; Thromboxane A2; Thromboxane-A Synthase; Thromboxanes | 1983 |
The role of prostacyclin and thromboxane A2 in the regulation of platelet behaviour.
Topics: Aspirin; Dipyridamole; Epoprostenol; Hemorrhage; Humans; Platelet Aggregation; Prostaglandins; Thrombosis; Thromboxane A2; Thromboxanes | 1980 |
1 trial(s) available for thromboxanes and Hemorrhage
| Article | Year |
|---|---|
A critical appraisal of the clinical efficiency of anti-platelet drugs.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Double-Blind Method; Hemorrhage; Humans; Myocardial Revascularization; Prospective Studies; Sulfinpyrazone; Thromboxanes | 1986 |
5 other study(ies) available for thromboxanes and Hemorrhage
| Article | Year |
|---|---|
PTGS1 compound heterozygosity impairs gene expression and platelet aggregation and is associated with severe bleeding complications.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Arachidonic Acid; Blood Platelets; Cells, Cultured; Cyclooxygenase 1; Genetic Association Studies; Hemorrhage; Heterozygote; Humans; Male; Platelet Aggregation; Platelet Function Tests; Polymorphism, Single Nucleotide; Postoperative Complications; Recurrence; Thromboxanes; Transcriptome | 2013 |
Congenital deficiency of thromboxane and prostacyclin.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acids; Aspirin; Blood Coagulation Tests; Blood Platelet Disorders; Cells, Cultured; Chromatography, Thin Layer; Epoprostenol; Hemorrhage; Humans; Male; Oxygenases; Plasma; Platelet Aggregation; Prostaglandins; Thromboxane A2; Thromboxanes | 1980 |
Thromboxane A2 in skin-bleeding-time blood and in clotted venous blood before and after administration of acetylsalicylic acid.
Topics: Adenosine Diphosphate; Adult; Aspirin; Bleeding Time; England; Hemorrhage; Hemostasis; Humans; Male; Platelet Aggregation; Platelet Function Tests; Skin; Sweden; Thromboxane A2; Thromboxane B2; Thromboxanes | 1983 |
Deficiency of platelet lipoxygenase activity in myeloproliferative disorders.
Topics: Blood Platelets; Hemorrhage; Hemostasis; Humans; Lipoxygenase; Myeloproliferative Disorders; Oxygen Consumption; Thromboembolism; Thrombosis; Thromboxanes | 1982 |
Immune-complex alveolitis in the rat: evidence for platelet activating factor and leukotrienes as mediators of the vascular lesions.
Topics: Alveolitis, Extrinsic Allergic; Animals; Azepines; Bronchoalveolar Lavage Fluid; Dinoprostone; Diterpenes; Econazole; Ginkgolides; Hemoglobins; Hemorrhage; Indomethacin; Lactones; Leukotriene B4; Leukotrienes; Lipoxygenase Inhibitors; Male; Platelet Activating Factor; Propionates; Quinolines; Rats; Rats, Inbred Strains; Thromboxanes; Triazoles | 1992 |